Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

29
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

39
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

34
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
34
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.0K
Overview
69.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cancer Treatment with Immune Checkpoint Inhibition in Solid Organ Transplant Recipients in Switzerland.

Cancers·2026
Same author

Complement Genetics in IgA Nephropathy: From Biological Plausibility to Tailored Therapy?

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Advances in therapy·2026
Same author

Impact of Disease Recurrence and Outcomes following Kidney Transplantation for Glomerulonephritis: A Prospective Nationwide Cohort Study.

Kidney360·2026
Same author

Single-kidney transplantation with discarded partner kidney vs. Dual kidney transplantation: results from a national cohort study.

BMC nephrology·2026
Same author

Is It Time to Review How We Use Proteinuria to Define Disease Activity in Glomerular Diseases?

Journal of the American Society of Nephrology : JASN·2026

相关实验视频

Updated: Jul 23, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

在移植中准补充途径

Dela Golshayan1, Nora Schwotzer2, Fadi Fakhouri2

  • 1Transplantation Center , Department of Medicine , Lausanne University Hospital and University of Lausanne , Lausanne , Switzerland.

Journal of the American Society of Nephrology : JASN
|July 13, 2023
PubMed
概括
此摘要是机器生成的。

补体系统在移植 (KTx) 中至关重要,但可能导致损伤. 新的补充阻断剂通过向涉及排斥和复发的途径,为更好的结果提供了希望.

更多相关视频

Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.7K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K

相关实验视频

Last Updated: Jul 23, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Mouse Kidney Transplantation: Models of Allograft Rejection
16:15

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

20.7K
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K

科学领域:

  • 免疫学 免疫学 免疫学
  • 移植医学 移植医学
  • 腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

  • 补体系统对于病原体清除至关重要,但在移植 (KTx) 后涉及移植损伤.
  • 人们越来越对补充激活的生物标志物感兴趣,以指导KTx疗法.
  • 以补充为驱动的疾病,如非典型的血溶性尿素综合征和C3球体病变,显示出对补充向治疗的潜力.

研究的目的:

  • 审查补充系统在移植损伤中的作用.
  • 讨论KTx.中新型补充抑制剂的潜力.
  • 在不同的KTx场景中探索优化补充阻塞的策略.

主要方法:

  • 关于移植中补体系统激活的当前文献的综述.
  • 对补充剂抑制剂的临床试验结果的分析.
  • 讨论新兴技术,如用于药物输送的ex vivo器官输液.

主要成果:

  • 对于非典型的血溶性尿素性综合征,C5阻塞是有效的,但对于高度敏感的KTx患者,效果较差.
  • 补充激活有助于缺血再输损伤和抗体介导排斥 (ABMR).
  • 新的补充剂阻断剂显示出缓解缺血再输,ABMR和复发的承诺.

结论:

  • 优化补充抑制的时间,策略和类型对于KTx是必要的.
  • 活体器官输液为有针对性的补充疗法提供了新的机会.
  • 新兴的补体阻断剂可能通过解决关键损伤途径,显著改善KTx结果.